← Leaderboards
Andrew S. Terker
Vanderbilt University Medical Center
$2,187,500
Attributed
$2,187,500
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $875K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$2,187,500 · 1
By mechanism
DP5$2,187,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University Medical Center
Same institution · by research overlap
- Lorraine B Ware$25,185,641
- Leslie S Gewin$4,534,041
- Eric J Delpire$19,818,885
- Keith T Wilson$21,094,933
- Christopher S. Williams$20,507,087
Others in their field
Other Rising Stars on “Kidney Epithelial Cell”
- Fouad T Chebib · Mayo Clinic Jacksonville$2,967,657
- Christian Furlan Freguia · Rise Therapeutics, Llc$2,086,639
- Robert Lippert · Kuda Therapeutics, Inc.$2,050,000
- Paulo Sebastian Caceres · Wayne State University$1,732,500
- Srinivas Malladi · Ut Southwestern Medical Center$1,584,374
- Samira Musah · Duke University$1,425,761
Research focus
Kidney Epithelial CellMediatingInjury To KidneyKidneyLaboratoriesMacrophageEpithelial CellsHomeostasisCellsInnovationKidney MetabolismAffectChronic Kidney FailureLinkAnimalsElectrophysiology (Science)EquilibriumFundingDietary PotassiumDisease ProgressionCell TypeAcademic Medical CentersCellular BiologyMolecular
Grant awards (4)
Innovative therapeutic approaches to treat chronic kidney disease$875,000
DP5 · FY2025 · OD · contact PI
Innovative therapeutic approaches to treat chronic kidney disease$437,500
DP5 · FY2024 · OD · contact PI
Innovative therapeutic approaches to treat chronic kidney disease$437,500
DP5 · FY2023 · OD · contact PI
Innovative therapeutic approaches to treat chronic kidney disease$437,500
DP5 · FY2022 · OD · contact PI